Skip to main content
Equibles
RNAZ logo

RNAZ · Transcode Therapeutics, Inc.

Track RNAZ — free

Use RNAZ with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RNAZ

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.28 -0.06 (-2.56%) At close · Aug 27
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”
View the 10-Q filed Aug 14, 2026
Market Cap
$39.62M
Shares
16.93M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RNAZ Short Interest Forecast

Equibles' model estimates 31,579 shares sold short for the August 31, 2026 settlement, +2.2% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
31,579 +2.2% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
37/100
Short interest 0.2% of shares — P24 Days to cover 1.5 — P32 Price vs VWAP -55.6% — P2 Short-volume trend +6.2% — P73 Short interest change +9.4% — P75 Worst FTD 0.01% of shares — P49

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 30,910 28,252 +2,658 1.51
    2026-07-31 28,252 34,446 -6,194 1.83
    2026-07-15 34,446 52,823 -18,377 1.00
    2026-06-30 52,823 56,527 -3,704 2.59
    2026-06-15 56,527 28,142 +28,385 1.00
    2026-05-29 28,142 36,265 -8,123 1.87
    2026-05-15 36,265 35,757 +508 4.07
    2026-04-30 35,757 41,071 -5,314 7.56
    2026-04-15 41,071 49,976 -8,905 6.39
    2026-03-31 49,976 68,334 -18,358 6.09
    2026-03-13 68,334 77,552 -9,218 5.39
    2026-02-27 77,552 113,877 -36,325 4.48
    2026-02-13 113,877 34,640 +79,237 1.00
    2026-01-30 34,640 59,701 -25,061 1.61
    2026-01-15 59,701 59,476 +225 1.00
    2025-12-31 59,476 41,544 +17,932 1.68
    2025-12-15 41,544 37,989 +3,555 2.55
    2025-11-28 37,989 35,717 +2,272 4.92
    2025-11-14 35,717 27,054 +8,663 2.31
    2025-10-31 27,054 58,698 -31,644 1.06
    2025-10-15 58,698 43,523 +15,175 1.00
    2025-09-30 43,523 58,692 -15,169 3.27
    2025-09-15 58,692 68,937 -10,245 5.59
    2025-08-29 68,937 83,366 -14,429 5.85

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1829635 CUSIP 89357L501 13F (30d) 8 filings 8 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)